These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10533812)

  • 1. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
    Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
    Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
    Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
    Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
    Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
    J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
    Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
    Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of urea-based peptidomimetic calpain inhibitors.
    Sanders ML; Donkor IO
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.
    Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D
    Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.
    Donkor IO; Korukonda R
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4806-8. PubMed ID: 18694642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
    Zeng Y; Li Q; Hanzlik RP; Aubé J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
    Korukonda R; Guan N; Dalton JT; Liu J; Donkor IO
    J Med Chem; 2006 Aug; 49(17):5282-90. PubMed ID: 16913717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
    van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
    J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.
    Meara JP; Rich DH
    J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of calpain inhibitory 6-pyridone 2-carboxamide derivatives.
    Lee KY; Lee KS; Jin C; Lee YS
    Eur J Med Chem; 2009 Mar; 44(3):1331-4. PubMed ID: 18396356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.
    Ando R; Sakaki T; Morinaka Y; Takahashi C; Tamao Y; Yoshii N; Katayama S; Saito K; Tokuyama H; Isaka M; Nakamura E
    Bioorg Med Chem; 1999 Apr; 7(4):571-9. PubMed ID: 10353636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of 3-sec-butyl-1-oxo-2,3-dihydroisoquinoline as inhibitors of mu-calpain.
    Chicharro R; Alonso M; Mazo MT; Arán VJ; Herradón B
    ChemMedChem; 2006 Jul; 1(7):710-4. PubMed ID: 16902923
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
    Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
    Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation.
    Jeon KH; Lee E; Jun KY; Eom JE; Kwak SY; Na Y; Kwon Y
    Eur J Med Chem; 2016 Oct; 121():433-444. PubMed ID: 27318120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
    Donkor IO; Korukonda R; Huang TL; LeCour L
    Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group.
    Schaschke N; Assfalg-Machleidt I; Machleidt W; Turk D; Moroder L
    Bioorg Med Chem; 1997 Sep; 5(9):1789-97. PubMed ID: 9354234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.